Osteoarthritis is a very common degenerative joint disease that progressively destroys the articular cartilage of the bones involved. These cartilages together with the synovial fluid have as their main task to absorb the vibrations and to minimize the frictions and stresses that develop inside a joint during movement or exercise. Their wear gradually causes negative symptoms such as pain, stiffness, tingling, swelling and therefore reduced joint function.
The onset of osteoarthritis can be due to many factors. Heredity, age, gender, obesity, lifestyle and intense sports activities are some of the factors that affect the likelihood of its occurrence.
As there is still no treatment that can bring the joint back to its healthy state, your doctor will use all the appropriate conservative methods that soothe the symptoms and aim to reduce the chance of its impairment. One of these methods with very good results is the injection of hyaluronic acid into the diseased joint.
Hyaluronic acid is present in normal human synovial fluid but in case of osteoarthritis its amount decreases with the simultaneous appearance of symptoms, prominently pain. The injectable viscoelastic supplements of hyaluronic acid lubricate the joint, help protect the cartilage, increase the range of motion, reduce pain and delay the progression of the disease. The products available in the Greek market are administered in a single injection or three injections (usually one injection per week).
CINGAL® is the first and only globally approved viscoelastic injectable hyaluronic acid supplement containing cortisone. It is a latest generation product, single dose, combines the properties of hyaluronic acid with those of cortisone and thus offers pain relief within 24 hours that lasts up to 26 weeks.
There are several products on the market that differ from each other in terms of composition and quality, resulting in poor or zero results for the patient.
The characteristics of a high quality viscoelastic hyaluronic acid supplement are:
All the above features are offered in the products of Anika Therapeutics (USA), which, through almost 30 years of experience and 35,000,000 cases worldwide, is considered the largest manufacturer of hyaluronic acid products in the USA and worldwide.
Anika Therapeutics’ products are now officially represented in Greece and Cyprus by our company Bekyras-Clinilab which always offers innovative and reliable solutions in Orthopedics and Traumatology in its 20-year action.
You can find the products of Anika Therapeutics that our company represents HERE.